Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Anterior Segment > AS-OCT may provide objective quantification of bleb function following glaucoma surgery
  • Anterior Segment

AS-OCT may provide objective quantification of bleb function following glaucoma surgery

Kerri Fitzgerald
data, research

Researchers assessed the use of anterior-segment optical coherence tomography (AS-OCT) to evaluate bleb function in post-surgical eyes and found that this “objective” method may help guide pharmacologic treatment and early surgical intervention in these patients. The study was presented at the 2024 ARVO Annual Meeting in Seattle, Washington.

The cross-sectional study included 204 blebs of 120 patients who had undergone trabeculectomy (n=96) or deep sclerectomy (n=108) surgery at least 1 year prior for their glaucoma. Median postoperative follow-up was 8.4 years (interquartile range, 3.2-9.0).

Outcomes were measured as:

  1. Complete success (CS), defined as intraocular pressure (IOP) £18 mmHg without medication
  2. Qualified success (QS), defined as IOP £18 mmHg with medication
  3. Failure (F), defined as IOP >18 mmHg

Among the patients included, 37.3% experienced CS, 32.7% QS, and 30.0% F. In trabeculectomy blebs, mean pixel intensity (PI) was significantly lower in CS compared with QS and F blebs. Sagittal area values of blebs were significantly greater in CS and QS cohorts compared with F in both the trabeculectomy and deep sclerectomy cohorts.

Researchers observed a “moderate” inverse correlation between maximal bleb height and PI in both trabeculectomy (P<.0001) and deep sclerectomy (P<.0001) groups.

“Image intensity and bleb area values of AS-OCT sagittal slices were significantly associated with CS compared to QS and F,” the authors concluded.

Reference

Posarelli M, Tan J, Roney M, et al, et al. Objective quantification of bleb function using swept source anterior-segment optical coherence tomography. Abstract 1868-B0231. Presented at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting, May 5-9, Seattle, Washington.

Share

Related Content

  • Anterior Segment

Anterior chamber IOLs tied to higher graft failure risk after DSEK in eyes without glaucoma

  • Glaucoma

Review finds low adverse event rates for glaucoma stents

  • Retina

Switching to aflibercept 8 mg extends treatment intervals in suboptimal nARMD responders

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Conference Roundup

Enhanced monofocal IOLs provide better intermediate vision with no rings or dysphotopsia

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon